UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Stability of sildenafil (Revatio®) dilutions in dextrose 5

Intensive care medicine, 2011-11, Vol.37 (11), p.1899-1899

2011

Volltextzugriff (PDF)

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

The pharmacogenomics journal, 2012-02, Vol.12 (1), p.62-67

2012

Volltextzugriff (PDF)

Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia

Human psychopharmacology, 2010-01, Vol.25 (1), p.84-91

2010

Volltextzugriff (PDF)

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

Progress in neuro-psychopharmacology & biological psychiatry, 2009-04, Vol.33 (3), p.475-481

2009

Volltextzugriff (PDF)

NMDA receptor genotypes associated with the vulnerability to develop dyskinesia

Translational psychiatry, 2012-01, Vol.2 (1), p.e67-e67

2012

Volltextzugriff (PDF)

Protein transduction domains and their utility in gene therapy

Current gene therapy, 2003-10, Vol.3 (5), p.486

2003

Volltextzugriff (PDF)

Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations

Digestive and liver disease, 2005-04, Vol.37 (4), p.282-297

2005

Volltextzugriff (PDF)

A disulfiram-alcohol reaction after inhalation of a salbutamol aerosol: a plausible interaction?

Tijdschrift voor psychiatrie, 2016, Vol.58 (5), p.407-410

2016

Volltextzugriff (PDF)

Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate—a validated assay for the clinic

Analytical and bioanalytical chemistry, 2011-07, Vol.400 (10), p.3473-3479

2011

Volltextzugriff (PDF)

Genetic Variation and the Risk of Haloperidol-Related Parkinsonism in Elderly Patients: A Candidate Gene Approach

Journal of clinical psychopharmacology, 2013-06, Vol.33 (3), p.405-410

2013

Volltextzugriff (PDF)

Association Between the 1291-C/G Polymorphism in the Adrenergic α-2a Receptor and the Metabolic Syndrome

Journal of clinical psychopharmacology, 2010-12, Vol.30 (6), p.667-671

2010

Volltextzugriff (PDF)

Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women

Menopause (New York, N.Y.), 2006-05, Vol.13 (3), p.517

2006

Volltextzugriff (PDF)

The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curaçao extrapyramidal syndromes study IX

Journal of psychopharmacology (Oxford), 2009-08, Vol.23 (6), p.652-659

2009

Volltextzugriff (PDF)

Association Between the 1291-C/G Polymorphism in the Adrenergic a-2a Receptor and the Metabolic Syndrome

Journal of clinical psychopharmacology, 2010-12, Vol.30 (6), p.667-671

2010

Volltextzugriff (PDF)

Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia

Progress in neuro-psychopharmacology & biological psychiatry, 2014, Vol.50, p.172-177

2014

Volltextzugriff (PDF)

Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbAlc values in patients on antipsychotic medication

Psychopharmacologia, 2011, Vol.216 (2), p.257-265

2011

Volltextzugriff (PDF)

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

Progress in neuro-psychopharmacology & biological psychiatry, 2009, Vol.33 (3), p.475-481

2009

Volltextzugriff (PDF)

PMH14 DUTCH ADAPTION OF THE COST-EFFECTIVENESS OF QUETIAPINE IN COMBINATION THERAPY IN THE MANAGEMENT OF ACUTE MANIA IN BIPOLAR I DISORDER

Value in health, 2005-11, Vol.8 (6), p.A199-A200

2005

Volltextzugriff (PDF)

The genetics of drug-related movement disorders, an umbrella review of meta-analyses

Molecular psychiatry, 2020-10, Vol.25 (10), p.2237-2250

2020

Volltextzugriff (PDF)

The genetics of drug-related movement disorders (DRMD), reply to comment: Antipsychotic-induced catatonia and neuroleptic malignant syndrome: The dark side of the moon

Molecular psychiatry, 2021-11, Vol.26 (11), p.6115-6115

2021

Volltextzugriff (PDF)

Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication

Psychopharmacology, 2011-07, Vol.216 (2), p.257-265

2011

Volltextzugriff (PDF)

Antipsychotic-induced movement disorders in long-stay psychiatric patients and 45 tag SNPs in 7 candidate genes: a prospective study

PloS one, 2012-12, Vol.7 (12), p.e50970

2012

Volltextzugriff (PDF)

Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations

SAGE open medicine, 2016-01, Vol.4, p.2050312116643673-2050312116643673

2016

Volltextzugriff (PDF)

Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia

Progress in neuro-psychopharmacology & biological psychiatry, 2014-04, Vol.50, p.172-177

2014

Volltextzugriff (PDF)

Cytochrome P450 2D6 poor metabolism, curvilinearity, and response: an intriguing observation requiring integration of psychopharmacology into pharmacogenetics

Journal of clinical psychopharmacology, 2013-12, Vol.33 (6), p.833-834

2013

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(25)
Science & Technology
(23)
Life Sciences & Biomedicine
(20)
Female
(15)
Male
(15)
Psychiatry
(14)
Adult
(11)
Middle Aged
(11)
Antipsychotic Agents - Adverse Effects
(10)
Antipsychotics
(9)
Genotype
(9)
Neurosciences & Neurology
(9)
Pharmacology & Pharmacy
(9)
Gene Frequency
(8)
Pharmacogenetics
(8)
Aged
(7)
Antipsychotic Agents - Therapeutic Use
(7)
Cross-Sectional Studies
(7)
Neurosciences
(7)
Alleles
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Stability of sildenafil (Revatio®) dilutions in dextrose 5

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

NMDA receptor genotypes associated with the vulnerability to develop dyskinesia

Protein transduction domains and their utility in gene therapy

Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations

A disulfiram-alcohol reaction after inhalation of a salbutamol aerosol: a plausible interaction?

Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate—a validated assay for the clinic

Genetic Variation and the Risk of Haloperidol-Related Parkinsonism in Elderly Patients: A Candidate Gene Approach

Association Between the 1291-C/G Polymorphism in the Adrenergic α-2a Receptor and the Metabolic Syndrome

Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women

The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curaçao extrapyramidal syndromes study IX

Association Between the 1291-C/G Polymorphism in the Adrenergic a-2a Receptor and the Metabolic Syndrome

Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia

Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbAlc values in patients on antipsychotic medication

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

PMH14 DUTCH ADAPTION OF THE COST-EFFECTIVENESS OF QUETIAPINE IN COMBINATION THERAPY IN THE MANAGEMENT OF ACUTE MANIA IN BIPOLAR I DISORDER

The genetics of drug-related movement disorders, an umbrella review of meta-analyses

The genetics of drug-related movement disorders (DRMD), reply to comment: Antipsychotic-induced catatonia and neuroleptic malignant syndrome: The dark side of the moon

Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication

Antipsychotic-induced movement disorders in long-stay psychiatric patients and 45 tag SNPs in 7 candidate genes: a prospective study

Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations

Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia

Cytochrome P450 2D6 poor metabolism, curvilinearity, and response: an intriguing observation requiring integration of psychopharmacology into pharmacogenetics

Suchergebnisse filtern